Image by jarun011OPINION – Originally created to help underserved and low-income patients access essential medications, the 340B program has evolved into something far removed from its original mission. Allowing 340B to grow without ensuring patient benefit or community reinvestment will only deepen disparities and harm the very populations the program was designed to support.
Blood sample, image by Jarun OntakraiOPINION: It would be a win-win for patients and public health if Americans were treated in a holistic and comprehensive manner.
A hospital patient experiencing pain . (Photo: jeep5d, via Shutterstock)OPINION: Although science and innovation are the cornerstones of the California economy, patients living with chronic pain have been largely left behind when it comes to significant medical breakthroughs. Beyond opioids, which can be effective but are also addictive, the choices that patients have available to treat pain remain limited to non-clinical options that only provide so much relief.
Laboratory testing of HCV. (Photo: Jarun Ontakrai, via Shutterstock)Millennials haven’t inherited the best batch of goods from baby boomers. They got a housing crisis, a shaky job market, and some enormous student loans. But until recently, viral hepatitis was the burden of boomers alone to bear. Now, millennials are also facing an outbreak of Hepatitis C Virus (HCV).